Clinical Trial

A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Evaluate the initial dose-effect and time-effect relationship of the injection product NC527-X
Trial Details
NCT Number NCT07538648
Lead Sponsor Zhejiang Cancer Hospital
Conditions Cancer
Enrollment 400 participants
Start Date 2025-12-24
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20